Open Beta
MetriLume

US marketsPRCT

SEC-sourced researchBeta

PRCT

PROCEPT BioRobotics Corp

Company comparison ↗

Data passport

CIK
0001588978
Exchange
Nasdaq
Business activity
— · SIC 3841
Financial inputs
6/6
Filing date
Oct 5, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 136,191,000.0000 USD; December 2024: 224,498,000.0000 USD; December 2025: 308,054,000.0000 USD308.1M USD0 USD0December 2023December 2024December 2025
PRCT · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2023136,191,000.0000Feb 26, 2026
December 2024224,498,000.0000Feb 26, 2026
December 2025308,054,000.0000Feb 26, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025308,054,000.0000-95,572,000.0000-48,985,000.0000508,081,000.0000142,211,000.0000Feb 26, 2026
December 2024224,498,000.0000-91,413,000.0000-99,213,000.0000534,017,000.0000131,797,000.0000Feb 26, 2026
December 2023136,191,000.0000-105,897,000.0000-108,003,000.0000——Feb 26, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$308.05MDecember 2025Feb 26, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$224.5MDecember 2024Feb 26, 202610-K
Net incomeNetIncomeLoss-$95.57MDecember 2025Feb 26, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$48.99MDecember 2025Feb 26, 202610-K
Total assetsAssets$508.08MDecember 2025Feb 26, 202610-K
Total liabilitiesLiabilities$142.21MDecember 2025Feb 26, 202610-K

New filings

Explore methodology ↗